0000950170-24-045120.txt : 20240417 0000950170-24-045120.hdr.sgml : 20240417 20240417161509 ACCESSION NUMBER: 0000950170-24-045120 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240415 FILED AS OF DATE: 20240417 DATE AS OF CHANGE: 20240417 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Apeiron Investment Group Ltd. CENTRAL INDEX KEY: 0001845711 ORGANIZATION NAME: STATE OF INCORPORATION: O1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40493 FILM NUMBER: 24851238 BUSINESS ADDRESS: STREET 1: BLOCK A, APT.12 STREET 2: IL-PIAZZETTA, TOWER ROAD CITY: SLIEMA STATE: O1 ZIP: SLM1605 BUSINESS PHONE: 44 7557 251 563 MAIL ADDRESS: STREET 1: BLOCK A, APT.12 STREET 2: IL-PIAZZETTA, TOWER ROAD CITY: SLIEMA STATE: O1 ZIP: SLM1605 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Angermayer Christian CENTRAL INDEX KEY: 0001845872 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40493 FILM NUMBER: 24851237 MAIL ADDRESS: STREET 1: BLOCK A, APT.12 STREET 2: IL-PIAZZETTA, TOWER ROAD CITY: SLIEMA STATE: O1 ZIP: SLM1605 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ATAI Life Sciences N.V. CENTRAL INDEX KEY: 0001840904 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: WALLSTRASSE 16 CITY: BERLIN STATE: 2M ZIP: 10179 BUSINESS PHONE: (617)-699-5876 MAIL ADDRESS: STREET 1: 524 BROADWAY CITY: NEW YORK STATE: NY ZIP: 10013 FORMER COMPANY: FORMER CONFORMED NAME: ATAI Life Sciences B.V. DATE OF NAME CHANGE: 20210115 4 1 ownership.xml 4 X0508 4 2024-04-15 0001840904 ATAI Life Sciences N.V. ATAI 0001845711 Apeiron Investment Group Ltd. 66 & 67 BEATRICE, AMERY STREET SILEMA O1 SLM1707 MALTA false false true false 0001845872 Angermayer Christian 66 & 67 AMERY STREET SILEMA O1 SLM 1707 MALTA false false true false false Convertible Notes 2024-04-15 4 J false 147950 D Common Shares 2367200 0 I By Apeiron Investment Group Ltd. Convertible Notes 2024-04-15 4 J false 147950 A 2024-04-15 2025-09-30 Common Shares 2367200 147950 I By Apeiron Investment Group Ltd. The conversion price for the Convertible Notes is EUR 17.00 per note. Represents an exchange of Convertible Notes issued by ATAI Life Sciences AG for Convertible Notes issued by the Issuer with substantially similar terms and economics. Each Convertible Note bears a notional principal amount of EUR 1.00. The reportable securities are held by Apeiron Investment Group Ltd. ("Apeiron"). Christian Angermayer, as the majority shareholder of Apeiron, may be deemed to beneficially own the securities. Apeiron Investment Group Ltd. By: /s/ Julien Hoefer, Director 2024-04-17 /s/ Christian Angermayer 2024-04-17